Infliximab for the treatment of posterior uveitis with retinal neovascularization in Behet disease.
Infliximab for the treatment of posterior uveitis with retinal neovascularization in Behet disease. is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Infliximab for the treatment of posterior uveitis with retinal neovascularization in Behet disease. have?
Infliximab for the treatment of posterior uveitis with retinal neovascularization in Behet disease. has 54 citations in the OpenAlex counts ScholarIQ stores.
When was Infliximab for the treatment of posterior uveitis with retinal neovascularization in Behet disease. published?
Infliximab for the treatment of posterior uveitis with retinal neovascularization in Behet disease. has 2004 year in the ScholarIQ index.
What is the open-access status of Infliximab for the treatment of posterior uveitis with retinal neovascularization in Behet disease.?
Infliximab for the treatment of posterior uveitis with retinal neovascularization in Behet disease. has closed oa status in the ScholarIQ index.
What is the DOI of Infliximab for the treatment of posterior uveitis with retinal neovascularization in Behet disease.?
The DOI for Infliximab for the treatment of posterior uveitis with retinal neovascularization in Behet disease. is on the source record.
What is the PMID of Infliximab for the treatment of posterior uveitis with retinal neovascularization in Behet disease.?
The PMID for Infliximab for the treatment of posterior uveitis with retinal neovascularization in Behet disease. is on the source record.
What is the OpenAlex record for Infliximab for the treatment of posterior uveitis with retinal neovascularization in Behet disease.?
The OpenAlex for Infliximab for the treatment of posterior uveitis with retinal neovascularization in Behet disease. is on the source record.